Salkind Gene: insider buys
Every open-market stock purchase reported by Salkind Gene to the SEC on Form 4.
Total bought$673.50K
Purchases2
Companies1
Last purchase filedNov 21, 2025
Return on these buys-76%
Salkind Gene has made 2 open-market purchases worth $673.50K in 1 company since Nov 18, 2025, according to SEC Form 4 filings. The most recent was filed on Nov 21, 2025: 50,000 shares of UPXI at $2.55 (Director), worth $127.50K. The largest was $546K of UPXI on Nov 17, 2025. Taken together, these purchases are down 76% at the latest closing prices (split-adjusted, weighted by amount).
Companies Salkind Gene bought
| Ticker | Company | Role | Buys | Total | Since buy | Last filed |
|---|---|---|---|---|---|---|
| UPXI | Upexi, Inc. | Director | 2 | $673.50K | -76% | Nov 21 |
Get the next Salkind Gene purchase on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll purchases
| Filed | Stock | Insider | Value | Shares | Price | Since buy | Stake | Trade | |
|---|---|---|---|---|---|---|---|---|---|
| Nov 21 | UPXIUpexi, Inc. | Salkind GeneindirectDirector | $127.50K | 50,000 | $2.55 | -74% | +30% | Nov 20 | SEC |
| Nov 18 | UPXIUpexi, Inc. | Salkind GeneindirectDirector | $546K | 200,000 | $2.73 | -76% | +54% | Nov 17 | SEC |